Objective: To test IgG Amyotrophic neuralgia patients from Switzerland. Samples: 21-2-0101, 21-2-0102, 21-2-0103, 21-2-0105, 21-2-0106, 21-3-0107. PROCEDURE: Fixation: in acetone -20ºC for 10 min at RT. Wash…
Objective: To test IgG Amyotrophic neuralgia patients from Switzerland (sample 21-2-099) and from the Hospital de Sant Pau (samples 370392 and 16013). We also had a…
Objective: To test IgG Amyotrophic neuralgia patient of Hospital de Sant Pau and a positive control of NF155. PROCEDURE: Samples: 370392 and NF155+. Fixation: in acetone -20ºC…
Objective: To test reactivity against Purkinje cells in MS patients and healthy controls (as controls in the previous NF155 IHC experiment) Samples: MS patients (14…
Objective: To test reactivity against Purkinje cells in NF155+ CIDP patients. Samples: 31-45, CSF: 216-09, 16-031, 16-042, 19-221, positive control (1.1) and 1.14 (post-treatment) PROCEDURE:…
Objective: To test reactivity against Purkinje cells in NF155+ CIDP patients. Samples: 6-30, positive control (1.1) PROCEDURE: Incubate with blocking solution (goat serum 5% in…
Objective: To test reactivity against Purkinje cells in NF155+ CIDP patients. We are going to perform it with two different protocols to decide which one…
Objective: To test CIDP patients from Romana (positive ICC for NF155, negative for ELISA). Samples: 37.2, 39, 41, 44, neg control, positive control. PROCEDURE: Fixation:…
Objective: To investigate Monkey’s Cerebellum and Cerebrum IH staining paterns in NF155 CIDP patients. Samples: 1.1, 2.1, 3.1, 4.1, 5.1 We used commercial slides from Euroimmune…
Objective: to test reactivity against peripheral nerve structures in healthy controls and patients with ALS and Myastenia Gravis Rach+ Protocol: blocking solution goat 5% 1h…